Darrin Stuart
12Patents
5h-index
26Co-inventors
66Inventor score
Filing activity: Jun 23, 1998 → Mar 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6120798A | Liposome-entrapped polynucleotide composition and method | Human Necessities | 39 | Expired |
| US7482367B2 | Substituted benzimidazoles and methods of their use | Emerging Cross-Sectional Technologies | 26 | Active |
| US9700557B2 | Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor | Human Necessities | 9 | Active |
| US9474754B2 | Pharmaceutical combinations comprising a B-RAF inhibitor, and EGFR inhibitor and optionally a PI3K-α inhibitor | Human Necessities | 7 | Active |
| US9913844B2 | Combination therapy | Chemistry; Metallurgy | 7 | Active |
| US10548894B2 | Combination therapy | Chemistry; Metallurgy | 4 | Active |
| US10973829B2 | Therapeutic uses of a C-RAF inhibitor | Human Necessities | 3 | Active |
| US8592459B2 | Substituted benzimidazoles and methods of their use | Emerging Cross-Sectional Technologies | 2 | Active |
| US7732465B2 | Substituted benzimidazoles and methods of their use | Emerging Cross-Sectional Technologies | 2 | Active |
| US12011449B2 | Therapeutic combinations comprising a c-RAF inhibitor | Human Necessities | 1 | Active |
| US11007194B2 | Method of treating a proliferative disease | Human Necessities | 1 | Active |
| US9241939B2 | Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.